An adjuvant is a substance added to a vaccine or immunologic product to enhance the recipient's immune response to the active antigen. In localization, the term appears in clinical trial documents, regulatory submissions, product monographs, investigator brochures, patient information, and healthcare provider materials; it is often described alongside the antigen in vaccine composition statements and safety discussions or comparative immunogenicity sections.
Angel Translation editorial reference · Confirm the rendering against your source and approved project terminology.
Check source meaning → confirm the preferred term → record approved variants and references.
Adjuvant terminology occurs in vaccine SmPCs, informed consent forms, clinical study reports, and public health translation. Translators must clearly separate the adjuvant from the antigen and excipient categories, especially when explaining adverse reactions or immunogenicity results to patients and study participants. Public-facing materials may need simplified phrasing without changing technical meaning.
A common mistake is treating an adjuvant as a preservative or excipient, or translating it as 'additive' in a way that minimizes its role. This can distort vaccine composition and safety information. In patient materials, mistranslating the adjuvant name may cause confusion with allergens or ingredients that contraindicate the vaccine. Such errors may undermine informed consent.
Check intended use, warnings, document versions and approved terminology with the project team. Translation supports documentation; it does not establish product approval or regulatory acceptance.
Provide approved terms and previous translations with the source files. Agree how variants, ambiguous wording and revisions will be reviewed. Terminology maintenance and any termbase handback are confirmed in the project scope. See the 8-step AI + expert workflow.
Medical-device registration files and technical specifications, in volume.
Read the published project →Quality manuals, SOPs, production-process and clinical-trial documentation.
Read the published project →Published scope shows related industry experience; it does not confirm that this specific term was used or reviewed in the project.
Include the source and target languages, file types, intended use, deadline and any approved termbase. Agree handling before sending sensitive files. Acknowledged in 4 hours, quoted in 24.
Prepare an inquiry email →Life Science solutions →File handling →A glossary entry is not an official standard or evidence of regulatory acceptance. Confirm current requirements for your project separately.